1 completed, 1 terminated, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Theodoros Foukakis: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes Garmin smartwatch, REBECCA Mobile application, REBECCA PC plug-in - Breast Neoplasms, Breast Cancer | Withdrawn | Theodoros Foukakis | 2024-03-31 | 2026-08-14 | ||
| HR+/HER2- Advanced Breast Cancer and Endocrine Resistance Palbociclib, Fulvestrant, Capecitabine - Breast Cancer Metastatic | Phase 2 | Terminated | Theodoros Foukakis | 42 | 2017-10-24 | 2024-03-08 |
| A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and Paclitaxel Bevacizumab, Paclitaxel - Breast Cancer | Phase 2 | Completed | Theodoros Foukakis | 33 | 2012-11-01 | 2019-02-27 |
Breast Neoplasms (2) · Polyneuropathies (1)
Bevacizumab (1) · Capecitabine (1) · Fulvestrant (1) · Paclitaxel (1) · palbociclib (1)
Sweden (3) · United Kingdom (1)
2016 (1)